Patients in Jersey will receive a more personalised cervical screening service from July, health bosses have said.

The Government of Jersey said it would be following recommendations from the UK National Screening Committee due to more accurate human papillomavirus (HPV) testing being available.

The screening detects HPV – the type of infection which is the main cause of cervical cancer.

The changes meant patients deemed to be at a low risk of cervical cancer would be tested less frequently, the government added.

From July, women or people with a cervix who are aged 25 to 49 and test negative, or have previously tested negative for HPV and therefore at low risk of cervical cancer, will be invited to screenings at five-year intervals rather than three, the government said.

Those whose samples indicated the presence of HPV, or had a recent history of HPV, would continue to be invited to more frequent screenings, it added.

Dr Fiona Nelson, clinical lead for cervical screening, said the new HPV test picked up problems earlier than older screening methods.

Dr Nelson added: “The HPV test is an objective test which means the sample is not dependent on a person looking at cells and making a judgment and this means there are fewer missed cases.”



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Revolutionizing biology education: Scientists film ‘giant’ mimivirus in action

The COVID-19 pandemic led to heightened public interest in learning about viruses and how they can cause diseases. There has been a lot of focus on communicating virology concepts to

Conflicting Advice on Covid Shots Likely To Ding Already Low Vaccine Rates, Experts Warn

More than three-quarters of American adults didn’t get a covid shot last season, a figure that health care experts warn could rise this year amid new U.S. government recommendations. The

Qué es el Proyecto 2025, una hoja de ruta para las medidas de salud de Trump

Probablemente pocos votantes esperaban que el presidente Donald Trump, en sus primeras semanas de mandato, recortara miles de millones de dólares de la principal agencia federal de investigación del cáncer